S269: MALE PATIENTS WITH SCD HAVE A HIGHER RISK OF CEREBROVASCULAR DISEASE, INCREASED INFLAMMATORY MARKERS, AND POORER RESPONSE TO HYDROXYUREA

S269: MALE PATIENTS WITH SCD HAVE A HIGHER RISK OF CEREBROVASCULAR DISEASE, INCREASED INFLAMMATORY MARKERS, AND POORER RESPONSE TO HYDROXYUREA

Bibliographic Details
Main Authors:	Margherita DI Mauro, Amina Nardo‐marino, Sara Stuart-Smith, Sara El Hoss, John Strouboulis, Stephan Menzel, John Gibson, David Rees, John Brewin
Format:	Article
Language:	English
Published:	Wiley 2023-08-01
Series:	HemaSphere
Online Access:	http://journals.lww.com/10.1097/01.HS9.0000967988.81245.b4

Similar Items

The Role of Hydroxyurea on Growth in Children with SCD
by: Zahrah Mohammed Alkashi
Published: (2023-01-01)

Hydroxyurea utilization and dose optimization in children with sickle cell disease (SCD)
by: Nour Alotaibi, et al.
Published: (2023-01-01)

Outcome of Hydroxyurea Use in SCD and Evaluation of Patients’ Perception and Experience in Nigeria
by: Reuben Ikechukwu Chianumba, et al.
Published: (2022-03-01)

Effect of Low Dose of Hydroxyurea in SCD Children with Arab-Indian phenotype- Local Experience
by: Zahra Jaber Hussein
Published: (2023-01-01)

THE ASSESSMENT OF CEREBROVASCULAR-DISEASE IN CHILDREN WITH SICKLE-CELL DISEASE (SCD)
by: Hewes, D, et al.
Published: (1993)

1957 07 269-269
by: H. J. Kruisinga
Published: (1957-07-01)

P1473: CREATING A RANDOM FOREST CLASSIFIER TO PREDICT HBF LEVELS IN SICKLE CELL DISEASE PATIENTS
by: C. Rakhit, et al.
Published: (2022-06-01)

Automating Pitted Red Blood Cell Counts Using Deep Neural Network Analysis: A New Method for Measuring Splenic Function in Sickle Cell Anaemia
by: Amina Nardo-Marino, et al.
Published: (2022-04-01)

Řeč na rozloučenou s Ivanem Havlem
by: Ivan Chvatík
Published: (2021-09-01)

P-017: POINT-OF-CARE DIAGNOSTIC FOR QUANTIFICATION OF FOETAL HAEMOGLOBIN (HB F) LEVELS IN MONITORING HYDROXYUREA THERAPY FOR CHILDREN WITH SICKLE CELL DISEASE (SCD) IN GHANA
by: SEGBEFIA C., et al.
Published: (2022-08-01)

Sicker and Poorer
by: Na Yin
Published: (2015-02-01)

P-042: POPULATION PHARMACOKINETICS AND PHARMACODYNAMICS ANALYSIS OF HYDROXYUREA, IN ADULT PATIENTS WITH SICKLE CELL DISEASE (SCD) RECEIVING BOTH TABLETS OR CAPSULES FORMULATIONS, AND EVALUATION OF DISEASE MARKERS
by: BARTOLUCCI P., et al.
Published: (2022-08-01)

Hydroxyurea-induced melanonychia
by: Michael G. Buontempo, BS, et al.
Published: (2023-12-01)

Qualitative Analysis of Hydroxyurea
by: Stéfanno Souza Santos, et al.
Published: (2020-07-01)

Qualitative Analysis of Hydroxyurea
by: Stéfanno Souza Santos, et al.
Published: (2020-07-01)

Qualitative Analysis of Hydroxyurea
by: Stéfanno Souza Santos, et al.
Published: (2020-07-01)

Qualitative Analysis of Hydroxyurea
by: Stéfanno Souza Santos, et al.
Published: (2020-07-01)

Sums of SCD sets and their applications to SCD operators and narrow operators
by: Kadets Vladimir, et al.
Published: (2010-02-01)

Deprivation amplification revisited; or, is it always true that poorer places have poorer access to resources for healthy diets and physical activity?
by: Macintyre Sally
Published: (2007-08-01)

Aprendiendo de Plečnik
by: Jelena Petric, et al.
Published: (2009-08-01)

Soudní ochrana člena společenství vlastníků jednotek
by: Tomáš Dvořák
Published: (2021-09-01)

Access barriers to care for patients with silent cerebrovascular disease (SCD) in rural China: A cross-sectional questionnaire-based study
by: Xiaoyu Wang, et al.
Published: (2023-12-01)

Hydroxyurea—The Good, the Bad and the Ugly
by: Marcelina W. Musiałek, et al.
Published: (2021-07-01)

Hydroxyurea-induced Tooth Discoloration
by: Muhammed Okuyucu, et al.
Published: (2020-02-01)

Blue Lunula Related with Hydroxyurea
by: Hava Üsküdar Teke, et al.
Published: (2013-03-01)

Adherence to Hydroxyurea and Patients’ Perceptions of Sickle Cell Disease and Hydroxyurea: A Cross-Sectional Study
by: Mohammed Ali Madkhali, et al.
Published: (2024-01-01)

sCD163, sCD28, sCD80, and sCTLA-4 as soluble marker candidates for detecting immunosenescence
by: Andrea Aprilia, et al.
Published: (2024-01-01)

More imports, poorer farmers
by: Mahavera, Sheridan
Published: (2023)

P1480: SPLENIC SEQUESTRATION IS MORE COMMON IN SCD-S/Β0-THAL THAN IN SCD-S/S PATIENTS: RESULTS FROM THE GERMAN SCD REGISTRY
by: P. Allard, et al.
Published: (2022-06-01)

The Effect of Antioxidants on the Properties of Red Blood Cells From Patients With Sickle Cell Anemia
by: Halima Al Balushi, et al.
Published: (2019-08-01)

ZGT 269/3 - Geofizik Pencarigalian II
by: PPSF, Pusat Pengajian Sains Fizik
Published: (2003)

NSP-SCD: a corpus construction protocol for child-directed print in understudied languages
by: Nag, S, et al.
Published: (2024)

Risk of classical Kaposi sarcoma by plasma levels of Epstein-Barr virus antibodies, sCD26, sCD23 and sCD30
by: Viviano Enza, et al.
Published: (2010-10-01)

The Use of Hydroxyurea in the Treatment of COVID-19
by: Foster Melissa Robin Bowman, et al.
Published: (2021-10-01)

Oral lesions associated with hydroxyurea treatment
by: Regina Mendonça, et al.
Published: (2011-01-01)

The burden and quality of life of caregivers of sickle cell anemia patients taking hydroxyurea versus those not taking hydroxyurea
by: Luiz Bernardino Lima da Silva, et al.
Published: (2012-01-01)

Cellular biophysical markers of hydroxyurea treatment in sickle cell disease
by: Du, E., et al.
Published: (2018)

ORGN 269-Electrophilic fluoroetherification to access fluorinated tetrahydrofurans
by: Wilkinson, S, et al.
Published: (2008)

Further thoughts on the syntax of Il. 5.265-269
by: Willi, A
Published: (2017)

Vol. 62 No. 269 (2024): JNMA: Published Monthly
by: Journal of Nepal Medical Association
Published: (2024-01-01)